These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30078111)

  • 1. N-methyl-D-aspartate Partial Agonist Enhanced Intensive Cognitive-Behavioral Therapy of Panic Disorder in Adolescents.
    Leyfer O; Carpenter A; Pincus D
    Child Psychiatry Hum Dev; 2019 Apr; 50(2):268-277. PubMed ID: 30078111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia?
    Pyrkosch L; Mumm J; Alt I; Fehm L; Fydrich T; Plag J; Ströhle A
    J Psychiatr Res; 2018 Oct; 105():153-163. PubMed ID: 30237105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER.
    Otto MW; Pollack MH; Dowd SM; Hofmann SG; Pearlson G; Szuhany KL; Gueorguieva R; Krystal JH; Simon NM; Tolin DF
    Depress Anxiety; 2016 Aug; 33(8):737-45. PubMed ID: 27315514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress.
    Scheeringa MS; Weems CF
    J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):69-77. PubMed ID: 24506079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
    Storch EA; Murphy TK; Goodman WK; Geffken GR; Lewin AB; Henin A; Micco JA; Sprich S; Wilhelm S; Bengtson M; Geller DA
    Biol Psychiatry; 2010 Dec; 68(11):1073-6. PubMed ID: 20817153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial.
    Smits JAJ; Zvolensky MJ; Otto MW; Piper ME; Baird SO; Kauffman BY; Lee-Furman E; Alavi N; Dutcher CD; Papini S; Rosenfield B; Rosenfield D
    Drug Alcohol Depend; 2020 Mar; 208():107877. PubMed ID: 32004998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No Effects of D-Cycloserine Enhancement in Exposure With Response Prevention Therapy in Panic Disorder With Agoraphobia: A Double-Blind, Randomized Controlled Trial.
    Hofmeijer-Sevink MK; Duits P; Rijkeboer MM; Hoogendoorn AW; van Megen HJ; Vulink NC; Denys DA; van den Hout MA; van Balkom AJ; Cath DC
    J Clin Psychopharmacol; 2017 Oct; 37(5):531-539. PubMed ID: 28820746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
    Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
    Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
    Nations KR; Smits JA; Tolin DF; Rothbaum BO; Hofmann SG; Tart CD; Lee A; Schipper J; Sjogren M; Xue D; Szegedi A; Otto MW
    J Clin Psychiatry; 2012 May; 73(5):647-53. PubMed ID: 22394471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update.
    Hofmann SG; Otto MW; Pollack MH; Smits JA
    Curr Psychiatry Rep; 2015 Jan; 17(1):532. PubMed ID: 25413638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
    Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
    JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents.
    Farrell LJ; Waters AM; Oar EL; Tiralongo E; Garbharran V; Alston-Knox C; McConnell H; Collings N; Zimmer-Gembeck M; Donovan CL; Testa C; Storch EA; Ollendick TH
    Brain Behav; 2018 Jun; 8(6):e00984. PubMed ID: 30106248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
    JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
    Mataix-Cols D; Fernández de la Cruz L; Monzani B; Rosenfield D; Andersson E; Pérez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hofmann SG; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Otto MW; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Scheeringa MS; Siewert-Siegmund A; Smits JAJ; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Davis M; Rück C; ; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner C; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P
    JAMA Psychiatry; 2017 May; 74(5):501-510. PubMed ID: 28122091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
    Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
    Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update.
    Hofmann SG; Sawyer AT; Asnaani A
    Curr Pharm Des; 2012; 18(35):5659-62. PubMed ID: 22632472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
    Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
    Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder.
    de Leeuw AS; van Megen HJ; Kahn RS; Westenberg HG
    Eur Psychiatry; 2017 Feb; 40():38-44. PubMed ID: 27837671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive processes in d-cycloserine augmented single-session exposure therapy for anxiety: A randomized placebo-controlled trial.
    Reinecke A; Nickless A; Browning M; Harmer CJ
    Behav Res Ther; 2020 Jun; 129():103607. PubMed ID: 32229324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.
    Barlow DH; Gorman JM; Shear MK; Woods SW
    JAMA; 2000 May; 283(19):2529-36. PubMed ID: 10815116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.